XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Leveraged Funds Turn Net-Short in CME Bitcoin Futures
Leveraged funds added a net 1,599 short contracts in CME Bitcoin futures in the week through Sept. 22, according to the latest Commitments of Traders report pub...
Sept. 30 Treasury Settlements: $58.42B Net Cash Flow
On September 30, $202 billion in US Treasury coupon payments settle on the same calendar date that $143. 58 billion in publicly held debt reaches maturity, prod...
Visa Stablecoin Dollar Volume Falls After Data Reset
The adjusted dollar volume figure that Visa publishes as part of its stablecoin activity monitoring was revised downward after the reset recalibrated the underl...
XRP ETFs Draw $75M as Solana Funds Hit 2026 High
XRP exchange-traded funds pulled in $75 million in net weekly inflows during the latest reporting period, while Solana-focused funds reached a new 2026 high, ac...
Solana SIMD-0649 Fee-Priority Proposal Closes Without Merge
Solana’s SIMD-0649, a governance proposal titled “Priority Ordering Within Entry Batches,” closed without a merge on September 25, 2026, four days after it was...
Bitcoin Spot ETFs Gain $2.39B Weekly as YTD Flows Turn Positive
Bitcoin spot ETFs recorded $2. 39 billion in weekly net inflows, a result significant enough to push the product category’s year-to-date flow total into positiv...
